Principais efeitos colaterais das drogas antiobsessivas e seu manejo
Autor(a) principal: | |
---|---|
Data de Publicação: | 2001 |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Brazilian Journal of Psychiatry (São Paulo. 1999. Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462001000600017 |
Resumo: | Selective serotonin reuptake inhibitors (SSRIs), clomipramine, and behavior therapy are the first line treatments for obsessive-compulsive (OCD) symptoms. One of the main reasons for treatment non-compliance and early discontinuation of medications by patients or premature change in prescriptions by clinicians are their side effects. Nausea, headache, insomnia, restlessness, sexual dysfunction, and tremors are common with SSRIs; hypotension, dry mouth, constipation, urinary retention, blurred vision, weight gain, sedation and cardiocirculatory problems, with clomipramine. The strategies and guidelines for these drugs' side effects management are here reviewed, based mainly in case reports and clinical experience. The clinician should be aware of the importance of addressing this issue, educating patients about the most frequent adverse reactions, and how to deal with them in order to prevent unwanted medication discontinuation, and enhance compliance with the treatment. |
id |
ABP-1_e317d2f3f50b58b3fd630fee0dc5a88e |
---|---|
oai_identifier_str |
oai:scielo:S1516-44462001000600017 |
network_acronym_str |
ABP-1 |
network_name_str |
Brazilian Journal of Psychiatry (São Paulo. 1999. Online) |
repository_id_str |
|
spelling |
Principais efeitos colaterais das drogas antiobsessivas e seu manejoObsessive-compulsive disorderTreatmentSelective serotonin reuptake inhibitorsClomipramineAdverse effectsManagementSelective serotonin reuptake inhibitors (SSRIs), clomipramine, and behavior therapy are the first line treatments for obsessive-compulsive (OCD) symptoms. One of the main reasons for treatment non-compliance and early discontinuation of medications by patients or premature change in prescriptions by clinicians are their side effects. Nausea, headache, insomnia, restlessness, sexual dysfunction, and tremors are common with SSRIs; hypotension, dry mouth, constipation, urinary retention, blurred vision, weight gain, sedation and cardiocirculatory problems, with clomipramine. The strategies and guidelines for these drugs' side effects management are here reviewed, based mainly in case reports and clinical experience. The clinician should be aware of the importance of addressing this issue, educating patients about the most frequent adverse reactions, and how to deal with them in order to prevent unwanted medication discontinuation, and enhance compliance with the treatment.Associação Brasileira de Psiquiatria2001-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462001000600017Brazilian Journal of Psychiatry v.23 suppl.2 2001reponame:Brazilian Journal of Psychiatry (São Paulo. 1999. Online)instname:Associação Brasileira de Psiquiatria (ABP)instacron:ABP10.1590/S1516-44462001000600017info:eu-repo/semantics/openAccessCordioli,Aristides Vpor2001-12-11T00:00:00Zoai:scielo:S1516-44462001000600017Revistahttp://www.bjp.org.br/ahead_of_print.asphttps://old.scielo.br/oai/scielo-oai.php||rbp@abpbrasil.org.br1809-452X1516-4446opendoar:2001-12-11T00:00Brazilian Journal of Psychiatry (São Paulo. 1999. Online) - Associação Brasileira de Psiquiatria (ABP)false |
dc.title.none.fl_str_mv |
Principais efeitos colaterais das drogas antiobsessivas e seu manejo |
title |
Principais efeitos colaterais das drogas antiobsessivas e seu manejo |
spellingShingle |
Principais efeitos colaterais das drogas antiobsessivas e seu manejo Cordioli,Aristides V Obsessive-compulsive disorder Treatment Selective serotonin reuptake inhibitors Clomipramine Adverse effects Management |
title_short |
Principais efeitos colaterais das drogas antiobsessivas e seu manejo |
title_full |
Principais efeitos colaterais das drogas antiobsessivas e seu manejo |
title_fullStr |
Principais efeitos colaterais das drogas antiobsessivas e seu manejo |
title_full_unstemmed |
Principais efeitos colaterais das drogas antiobsessivas e seu manejo |
title_sort |
Principais efeitos colaterais das drogas antiobsessivas e seu manejo |
author |
Cordioli,Aristides V |
author_facet |
Cordioli,Aristides V |
author_role |
author |
dc.contributor.author.fl_str_mv |
Cordioli,Aristides V |
dc.subject.por.fl_str_mv |
Obsessive-compulsive disorder Treatment Selective serotonin reuptake inhibitors Clomipramine Adverse effects Management |
topic |
Obsessive-compulsive disorder Treatment Selective serotonin reuptake inhibitors Clomipramine Adverse effects Management |
description |
Selective serotonin reuptake inhibitors (SSRIs), clomipramine, and behavior therapy are the first line treatments for obsessive-compulsive (OCD) symptoms. One of the main reasons for treatment non-compliance and early discontinuation of medications by patients or premature change in prescriptions by clinicians are their side effects. Nausea, headache, insomnia, restlessness, sexual dysfunction, and tremors are common with SSRIs; hypotension, dry mouth, constipation, urinary retention, blurred vision, weight gain, sedation and cardiocirculatory problems, with clomipramine. The strategies and guidelines for these drugs' side effects management are here reviewed, based mainly in case reports and clinical experience. The clinician should be aware of the importance of addressing this issue, educating patients about the most frequent adverse reactions, and how to deal with them in order to prevent unwanted medication discontinuation, and enhance compliance with the treatment. |
publishDate |
2001 |
dc.date.none.fl_str_mv |
2001-10-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462001000600017 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462001000600017 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
10.1590/S1516-44462001000600017 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Brasileira de Psiquiatria |
publisher.none.fl_str_mv |
Associação Brasileira de Psiquiatria |
dc.source.none.fl_str_mv |
Brazilian Journal of Psychiatry v.23 suppl.2 2001 reponame:Brazilian Journal of Psychiatry (São Paulo. 1999. Online) instname:Associação Brasileira de Psiquiatria (ABP) instacron:ABP |
instname_str |
Associação Brasileira de Psiquiatria (ABP) |
instacron_str |
ABP |
institution |
ABP |
reponame_str |
Brazilian Journal of Psychiatry (São Paulo. 1999. Online) |
collection |
Brazilian Journal of Psychiatry (São Paulo. 1999. Online) |
repository.name.fl_str_mv |
Brazilian Journal of Psychiatry (São Paulo. 1999. Online) - Associação Brasileira de Psiquiatria (ABP) |
repository.mail.fl_str_mv |
||rbp@abpbrasil.org.br |
_version_ |
1754212552067252224 |